p38 and a p38-Interacting Protein Are Critical for Downregulation of E-Cadherin during Mouse Gastrulation  by Zohn, Irene E. et al.
p38 and a p38-Interacting Protein Are
Critical for Downregulation of
E-Cadherin during Mouse Gastrulation
Irene E. Zohn,1,5 Yingqiu Li,3 Edward Y. Skolnik,4 Kathryn V. Anderson,2 Jiahuai Han,3 and Lee Niswander1,*
1Howard Hughes Medical Institute, Department of Pediatrics, Section of Developmental Biology, University of Colorado at Denver
and Health Sciences Center, Aurora, CO 80045, USA
2Developmental Biology Program, Sloan-Kettering Institute, New York, NY 10021, USA
3Department of Immunology, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, CA 92037, USA
4New York University Medical Center, Skirball Institute of Biomolecular Medicine, Department of Pharmacology, 540 First Avenue,
New York, NY 10016, USA
5Present Address: Center for Neuroscience Research, Children’s Research Institute, Children’s National Medical Center,
Washington, DC 20010, USA
*Contact: lee.niswander@uchsc.edu
DOI 10.1016/j.cell.2006.03.048SUMMARY
During vertebrate gastrulation, an epithelial to
mesenchymal transition (EMT) is necessary for
migration of mesoderm from the primitive
streak. We demonstrate that p38 MAP kinase
and a p38-interacting protein (p38IP) are criti-
cally required for downregulation of E-cadherin
during gastrulation. In an ENU-mutagenesis
screen we identified the droopy eye (drey)
mutation, which affects splicing of p38IP.
p38IPdreymutant embryos display incompletely
penetrant defects in neural tube closure, eyede-
velopment, and gastrulation. A stronger allele
(p38IPRRK) exhibits gastrulation defects in
which mesoderm migration is defective due to
deficiency in E-cadherin protein downregula-
tion in the primitive streak. We show that p38IP
binds directly to p38 and is required for p38 ac-
tivation in vivo. Moreover, both p38 and p38IP
are required for E-cadherin downregulation dur-
ing gastrulation. Finally, p38 regulates E-cad-
herin protein expression downstream from
NCK-interacting kinase (NIK) and independently
of the regulation of transcription by Fibroblast
Growth Factor (Fgf) signaling and Snail.
INTRODUCTION
Gastrulation in the mouse embryo begins at embryonic
day 6.25 (E6.25) and results in the formation of the three
definitive germ layers and establishment of the embryonic
body plan (reviewed in Tam and Behringer, 1997). During
gastrulation, the epiblast is a cup-like structure nestledwithin the visceral endoderm (Figure 3I). Mesoderm cells
migrate through the primitive streak in the posterior region
of the epiblast and undergo an epithelial to mesenchymal
transition (EMT) and migrate away from the primitive
streak. These morphogenic movements are mediated by
regulated changes in cell adhesion (reviewed in Shook
and Keller, 2003).
Fibroblast Growth Factor (Fgf) signaling in the primitive
streak regulates EMT during mouse gastrulation. Fgf8
and Fgfr1 mutant embryos display gastrulation defects in
which mesoderm fails to migrate away from the streak
(Deng et al., 1994; Sun et al., 1999; Yamaguchi et al.,
1994). Significantly, Fgfr1 mutant embryos fail to express
Snail and to downregulate expression of E-cadherin (Cir-
una and Rossant, 2001). Snail acts as a transcriptional re-
pressor to inhibitE-cadherin expression (Batlle et al., 2000;
Cano et al., 2000), and inSnailmutant embryosE-cadherin
is not downregulated (Carver et al., 2001). These data sug-
gest a molecular pathway where Fgf signaling, through
regulation of Snail expression, downregulates E-cadherin
expression to promote EMT during gastrulation.
Targeted disruption of NCK- interacting kinase/Map4k4
(NIK) results in a similar phenotype to Fgfr1 mutant em-
bryos in which mesoderm accumulates in the primitive
streak (Deng et al., 1994; Xue et al., 2001; Yamaguchi
et al., 1994). In contrast to Fgfr1 mutants, NIK mutant em-
bryos express molecular markers of mesoderm develop-
ment, indicating that mesoderm is properly specified al-
though it does not migrate. While the signal transduction
pathway(s) downstream of Fgf and NIK in the gastrulating
embryo have not been elucidated, both can activate MAPK
cascades (reviewed in Bottcher and Niehrs, 2005; Buday
et al., 2002). MAPKs are a family of conserved serine/thre-
onine protein kinases that function in kinase cascades, re-
sulting in phosphorylation and activation of transcription
factors and/or additional kinases (reviewed in Chang and
Karin, 2001; New and Han, 1998). In mice, the p38 groupCell 125, 957–969, June 2, 2006 ª2006 Elsevier Inc. 957
Figure 1. The drey Mouse Mutation Disrupts a p38-Interacting Protein
(A–D) drey/ mutant embryos exhibit a range of phenotypes. (A) E12.5 mutant embryo with exencephaly (between red arrows) and the ‘‘droopy eye’’
phenotype. (B) E12.5 mutant with spina bifida (between red arrows). (C and D) E10.5 mutant embryos demonstrating defects in mesoderm develop-
ment. (C) Embryo exhibits growth retardation, failure to turn, exencephaly, and various mesoderm defects including lack of somites. (D) Embryo ex-
hibits growth retardation, posterior truncations, and an open neural tube.
(E) Genetic map of drey interval on mouse chromosome 3. The number of recombination events over number of opportunities for recombination is
indicated for each polymorphic marker. Markers D3ski16, D3ski13, D3ski12, and D3ski4 never separated from the drey phenotypes. Within this in-
terval are six transcription units: BM02 (BM-002/ubiquitin folding modifier), Trpc4 (receptor-activated cation channel), Postn (periostin precursor [PN]/
osteoblast-specific factor 3[OSF2]), D3Ertd300e (p38-Interacting Protein), Exosc8 (exosome complex exonuclease or RRP43/ribosomal processing
protein 43), and Alg5 (Dolichyl-phosphate b-glucosyltransferase).
(F) The drey ENU-induced mutation results in a T to C transition (red) in the splice donor consensus sequence following exon 14 (blue box) in
D3Ertd300e encoding a p38-interacting protein (p38IP).
(G) Predicted protein motifs in p38IP: a nuclear localization sequence (NLS, red), PEST sequence (black), and Serine-rich regions (S-Rich, blue). The
human and mouse transcripts have 2202 bp and 1590 bp open reading frames that encode 733 and 530 amino acid proteins, respectively. The
p38IPdrey and p38IPRRK mutations result in truncated proteins at 317 and 133 amino acids, respectively.958 Cell 125, 957–969, June 2, 2006 ª2006 Elsevier Inc.
is represented by four genes: p38a/MAPK14, p38b/
MAPK11, p38d/MAPK13, and p38g/MAPK12. Deletion of
either the p38g or p38b genes does not result in any de-
tectable developmental phenotype, while a deletion of
the p38d gene has not been reported (reviewed in Kuida
and Boucher, 2004). p38a/ embryos die during midges-
tation due to a placental defect (Adams et al., 2000; Mud-
gett et al., 2000). However, treatment of early mouse em-
bryos with the drug SB203580 to inhibit both p38a and
p38b, but not p38d or p38g, suggests that both p38a and
p38b are required for preimplantation development (Mae-
kawa et al., 2005; Natale et al., 2004). These experiments
also suggest that double mutant embryos would not likely
survive preimplantation development, and alternative ap-
proaches are needed to determine the full range of activi-
ties of the p38 family during development.
Using a forward genetic screen, we have identified a se-
ries of ENU-induced mutations that disrupt neural tube clo-
sure or gastrulation in the mouse embryo (Garcia-Garcia
et al., 2005; Kasarskis et al., 1998; Zohn et al., 2005).
Here we describe an ENU-induced splicing mutation in
the droopy eye (drey) line that results in a variety of incom-
pletely penetrant phenotypes including defects in neural
tube closure and gastrulation. Strikingly, a stronger allele
results in highly penetrant gastrulation defects, in particu-
lar defects in migration of mesoderm from the primitive
streak. We reveal that drey encodes a p38-interacting pro-
tein (p38IP) and is required for p38 activation in vivo. Fur-
thermore, we demonstrate that p38 activation is required
for downregulation of E-cadherin protein. Finally we pres-
ent evidence that p38 acts downstream from NIK, in a par-
allel pathway to Fgfs and Snail, to ensure a robust EMT by
regulating expression of the E-cadherin protein and tran-
script, respectively.
RESULTS
Neural Tube, Eye, and Mesoderm Defects in drey
Embryos
As part of our ongoing ENU-mutagenesis screen, we iden-
tified the mutant mouse line droopy eye (drey). Mutant em-
bryos exhibit a variety of incompletely penetrant defects
including expansion of the retinal-pigmented epithelium
over the dorsal half of the eye (present in 116/147 embryos
analyzed; 79%) and neural tube closure defects consisting
of spina bifida (21/147; 14%) and exencephaly (81/147;
55%; Figures 1A and 1B). A small percentage of embryos
(4/147; 3%) show severe defects in mesoderm develop-
ment including a malformed allantois, somite defects,
and posterior mesoderm truncations (Figures 1C and
1D). Conversely, some drey mutant embryos (7/31; 23%)
do not exhibit any detectible phenotypes, and in a fewrare cases, drey mutant animals survive postnatally (4/
92; 4%) and could reproduce (1/92; 1%).
drey Encodes a p38-Interacting Protein
Using meiotic recombination mapping, the drey mutation
mapped to a 1 Mb region on mouse chromosome 3,
which contains six predicted transcripts including the
D3Ertd300e transcript (Figure 1E; NCBI accession
#BC052702). D3Ertd300e is annotated as a p38-interact-
ing protein based on identification of the human homolog
in a yeast two-hybrid screen using p38a as bait (Y.L. and
J.H., unpublished data; NCBI accession #AF093250). Fur-
thermore, we demonstrate that D3Ertd300e interacts with
p38 MAPK and is required for its activity in vivo (see below
and Figure 2), thus we rename D3Ertd300e: p38-interact-
ing protein (p38IP). There is very little known about the
p38IP gene and there are no apparent studies of p38IP
function. Human p38IP/C13orf19 was found to have al-
tered expression in prostate cancers relative to normal
prostate tissue (Schmidt et al., 2001, 2005) and to be ex-
pressed in human hematopoietic stem cells (Gomes
et al., 2002). Since p38 MAP Kinase has been shown to
regulate a variety of biological processes such as apopto-
sis, proliferation, and gene expression (reviewed in New
and Han, 1998), p38IP was an interesting candidate to
test as the responsible gene for a regulator of neural tube
closure. Upon sequencing drey genomic DNA around the
splice junctions of the predicted p38IP transcript, a T to
C transition was identified in the splice donor consensus
sequence at the end of exon 14 (Figure 1F). The p38IP pro-
tein contains a classical nuclear localization sequence, a
PEST sequence, and a serine-rich region at the C terminus
(Figure 1G).
To determine if the mutation disrupts p38IP splicing, an
RT-PCR assay was performed using primers flanking
exon 14 (Figure 1H). Amplification of wild-type cDNA re-
sulted in a single 500 bp PCR product, whereas mutant
cDNA produced multiple products including a 500 bp
product at low abundance, indicating that a small propor-
tion of transcripts are spliced normally in mutant embryos.
Sequencing of the aberrantly spliced transcripts indicates
that they encode disrupted proteins with premature stop
codons encountered at either 951 or 948 bp. The small
proportion of normal transcripts produced likely accounts
for the incomplete penetrance of phenotypes observed in
drey mutant embryos.
To confirm that mutation of p38IP is responsible for the
developmental defects in p38IPdrey mutants, a second al-
lele of p38IP was obtained from the BayGenomics gene-
trap resource and used in a complementation test cross.
ES cell clone RRK304 (designated p38IPRRK) contains an
insertion in the seventh intron of the p38IP gene, which is(H) Splicing of p38IP transcript in p38IP+/+ (+/+) and p38IPdrey/drey (/) embryos. Some transcripts are spliced normally in p38IPdrey/drey embryos
whereas the majority of transcripts use alternate splice donor sequences.
(I) The p38IPRRK gene trap allele fails to complement p38IPdrey as p38IPdrey/RRK embryos at E10.5 exhibit exencephaly (between red arrows, I). p38IP
mRNA is expressed ubiquitously in E7.5 embryos (J).Cell 125, 957–969, June 2, 2006 ª2006 Elsevier Inc. 959
Figure 2. p38IP Interacts with p38a and Is Required for p38 Activation In Vivo
(A) Flag-p38a was coexpressed with YFP-p38IP in 293T cells. Immunoprecipitation was performed with anti-Flag (a-Flag) M2 agarose beads 24 hr
after transfection, and the immunoprecipitates and cell lysates (WCL) analyzed by Western blot using anti-Flag (a-Flag) and anti-YFP (a-YFP) anti-
bodies.
(B) 293T cells were lysed and immunoprecipitated with either preimmune serum (PI) or anti-p38IP antibody (a-p38IP) from two different His-p38IP
immunized rabbits. The immunoprecipitates were analyzed by Western blot using anti-p38IP (a-p38IP) and anti-p38 (a-p38) antibodies.
(C) HF7c yeast cells were cotransfected with pGAD424-p38IP and pGBT9 (marked as V), pGBT9-p38a(AF) (a), pGBT9-p38b(AF) (b), pGBT9-p38g(AF)
(g), or pGBT9-p38d(AF) (d). The cells were plated on minus leucine and tryptophan medium (SD-LW) to select cells cotransfected with pGAD424 and
pGBT vectors.
(D) The same as (C) except medium lacking additional histidine (SD-LWH) was used to select for interaction.
(E) b-galactosidase colony-lift assay of the cells shown in (C).
(F) b-galactosidase activity in cells cotransfected with pGAD424-p38IP and pGBT9 (vector), pGAD424-p53 and pGBT9 Large T (p53/Large T), or
pGAD424-p38IP and pGBT9 p38a(AF).
(G) AH109 yeast cells were cotransfected with pGAD424-p38IP(human), pGAD424-p38IP(mouse), pGAD424-N-terminal-p38IP(1–383) or pGAD424-
C-terminal p38IP(380–733), and pGBT9 or pGBT9-p38a(AF) and plated on medium as above. Interaction was determined by growth on medium
lacking additional histidine (SD-LWH), b-galactosidase activity, and by coimmunoprecipitation of in vitro translated p38IP(human), N-terminal
p38IP(1–383), and C-terminal p38IP(380–733) with p38a (ND = not determined).
(H–M) Analysis of phosphorylation of p38, ATF2, and CREB in the eye of E12.5 wild-type (H, J, and L) and mutant (I, K, and M) embryos. (H0)–(M0) shows
higher magnification of boxed region in (H)–(M). Phosphorylated p38 is detected in the retinal-pigmented epithelium (RPE), neural retina (NR), and the
lens of wild-type embryos (H and H0), whereas it is only detected in a few scattered cells in the p38IPdrey/drey eye (I and I0). Phosphorylated CREB is
detected in RPE, NR, and lens of wild-type eyes (J and J0) but is not activated in RPE or NR of the p38IPdrey/drey eye (K and K0). Phosphorylated-ATF2 is
detected in the RPE, NR, and lens of wild-type (L and L0) but is downregulated in the RPE of the p38IPdrey/drey eye (M and M0 ).predicted to fuse the first 133 amino acids of p38IP to a b-
galactosidase and neomycin phosphotransferase cas-
sette. To determine the fidelity of splicing of the genetrap
cassette into the p38IP transcript, RT-PCR using primers960 Cell 125, 957–969, June 2, 2006 ª2006 Elsevier Inc.that flank exons 7 and 8 was performed. The absence of
any detectable normal transcript in p38IPRRK/RRK mutant
embryos suggests that this allele is likely a null or a severe
hypomorph (data not shown). Similar to p38IPdrey/drey
mutant embryos, transheterozygous p38IPdrey/RRK mutant
embryos exhibit incompletely penetrant phenotypes that
range from gastrulation and neural tube defects to mor-
phologically normal embryos (Figure 1I and data not
shown). This genetic experiment confirms that the muta-
tion in p38IP is responsible for the drey phenotypes.
To determine if p38IP is expressed in a pattern that is
consistent with a role in regulation of gastrulation or neu-
rulation, p38IP expression was examined by in situ hybrid-
ization using an antisense RNA probe against the p38IP
transcript in wild-type embryos and LacZ in p38IPRRK/+
embryos. These experiments reveal that the p38IP tran-
script is expressed ubiquitously at all stages examined
(E7.5–E12.5; Figure 1J and data not shown).
p38IP Is Required for Activation of p38 In Vivo
As mentioned above, we identified the human homolog of
p38IP in a yeast two-hybrid screen using p38a as bait. Six
colonies representing three different genes were identified
out of 23 107 colonies screened. Two of the proteins were
known p38a interactors: the p38a substrate MK2 and Pax6
(Mikkola et al., 1999; Stokoe et al., 1992). One undescribed
353 amino acid peptide was identified, and because there
was no information available about the gene, we named it
p38-Interacting Protein (p38IP) (Y.L. and J.H., unpublished
data; NCBI accession #AF093250). To confirm the interac-
tion, we tested the ability of p38IP to interact with p38a in
coimmunoprecipitation assays. When YFP-tagged p38IP
and Flag-tagged p38a are coexpressed in 293T cells,
p38IP associates with p38a (Figure 2A). Interaction be-
tween endogenous p38IP and p38a is also detected fol-
lowing immunoprecipitation of untransfected 293T cells
(Figure 2B). To determine the specificity of p38IP binding
to p38, p38 isoforms with the TGY dual phosphorylation
site changed to AGF were used in a yeast two-hybrid inter-
action assay (Figures 2C–2F). Cells cotransfected with
p38IP and p38aare able to grow on SD-LWH media and in-
duce b-galactosidase activity, indicating an interaction,
whereas p38IP does not interact by these assays in yeast
with p38b, p38d, p38g, or vector control pGBT9 (Figures
2C–2E). Coexpression of p38IP and p38a is able to signif-
icantly induce b-galactosidase activity comparable to that
of p53 and large T antigen (Figure 2F).
In comparison to human p38IP, mouse p38IP ends at
amino acid 530, resulting in a single N-terminal Serine-rich
domain. To determine if the mouse p38IP also interacts
with p38, we tested binding in a yeast two-hybrid assay.
Identical to human p38IP, mouse p38IP only interacted
with the p38a isoform when scored for growth on medium
lacking histidine (SD-LWH) and induction of b-galactosi-
dase (Figure 2G and data not shown). To determine if the
truncated p38IP proteins that are potentially produced in
p38IPdrey and p38IPRRK mutant mice (Figure 1G) can bind
to p38a, we mapped the binding domain in the p38IP
protein. Yeast coexpressing N-terminal p38IP (1–383)
and p38a are not able to grow on SD-LWH media or in-
duce the b-galactosidase reporter, indicating that p38IP
does not interact with this fragment. In contrast, cellscotransfected with C-terminal p38IP (380–733) and p38a
are able to grow on SD-LWH media and induce b-galacto-
sidase, indicating that the p38a interaction domain is in the
C-terminal region of the protein. The interaction domain
also was confirmed in a coimmunoprecipitation assay
using in vitro translated proteins (data summarized in
Figure 2G). These data reveal that the truncated proteins
potentially produced by the two mutant alleles of p38IP
do not bind p38a.
To determine the in vivo relevance of the interaction be-
tween p38IP and p38, we examined whether p38 activity
was misregulated in thedreymutant mouse. The activation
of p38 and its downstream substrates CREB and ATF2
were examined using phospho-specific antibodies in
wild-type and drey mutant eyes, an organ that is affected
by p38IP truncation. In the wild-type E12.5 eye, p38,
CREB, and ATF2 are phosphorylated in the retinal-pig-
mented epithelium (RPE; p38: 53%, CREB: 67%, ATF2:
89% of cells), neural retina (NR; p38: 69%, CREB: 57%,
ATF2: 79% of cells), and lens (p38: 44%, CREB: 46%,
ATF2: 74% of cells; Figures 2H, 2J, and 2L). In contrast,
in the p38IPdrey/drey mutant eye, phosphorylated p38 is
only detected at low levels in a few cells scattered through-
out the eye (RPE: 1%; NR: 6%; lens: 7% of cells; Figure 2I).
The phosphorylation of p38 substrates is not detected in
specific cell layers in p38IPdrey/drey mutant eyes. Phos-
phorylated CREB is detected in the lens of p38IPdrey/drey
eyes (53%) but is greatly reduced in the RPE (4%) and neu-
ral retina (4%; Figure 2K). While phosphorylated ATF2 is
detected in the neural retina (88%) and lens (75%) of
p38IPdrey/drey eyes, it is significantly reduced in the RPE
(9%; Figure 2M). These data reveal that p38IP interacts
with p38a, and in mutant embryonic tissues in which trun-
cated p38IP cannot bind p38a, activation of p38 and
downstream substrates is impaired in vivo.
p38IP Is Required for Development of Mesoderm
To investigate further the role of p38IP in embryogenesis,
we examined mutant phenotypes in mouse embryos ho-
mozygous for the more severe p38IPRRK allele (Figure 3).
E9.5 and E10.5 mutant embryos exhibit multiple develop-
mental defects consistent with abnormalities in develop-
ment of mesoderm (Figures 3A–3D). Yolk sac membranes
are wrinkled and poorly vascularized, and mutants develop
a malformed allantois that fails to fuse to the chorion. Mu-
tant embryos are necrotic, developmentally delayed, ex-
hibit misshapen head folds and exencephaly, and fail to
form somites or form only a few anterior somites.
These widespread abnormalities in development of
mesodermally derived tissues could originate during gas-
trulation when mesoderm is specified and migrates. At
gastrulation, p38IPRRK/RRK mutant embryos contain
a mass of cells on the posterior side (Figures 3E and 3F).
Histological analysis reveals that a significant proportion
of the mesoderm failed to migrate away from the primitive
streak (Figures 3G and 3H). Mesoderm migration defects
were consistently observed although the extent varied
between mutants.Cell 125, 957–969, June 2, 2006 ª2006 Elsevier Inc. 961
Figure 3. Defects in Mesoderm Development and Migration in p38IPRRK/RRK Mutant Embryos
At E10.5, p38IPRRK/RRK mutant embryos (B) exhibit exencephaly (between red arrows), are necrotic, are developmentally delayed, and exhibit defects
in development of extraembryonic mesoderm such as malformed and avascular yolk sacs (YS) compared to sibling controls (A). E9.5 p38IPRRK/RRK
mutant embryos (D) are developmentally delayed with enlarged head folds (red arrow) and exhibit multiple defects in mesoderm development, such
as lack of somites (yellow arrow) and malformed allantois (white arrow), as compared with sibling controls (C). At E7.5, a mass of cells is observed
accumulating in the primitive streak of p38IPRRK/RRK mutant embryos (red *, F) compared with controls (E). Hematoxylin and Eosin (H&E) staining of
E7.5 p38IP+/+ (G) and p38IPRRK/RRK mutant (H) embryos demonstrates that mesoderm cells accumulate in the mutant primitive streak (black *). (I)
Schematic of gastrulation in the mouse embryo. The epiblast of the E7.5 gastrula stage mouse embryo is shaped like a cup nestled within a cup
of visceral endoderm. Mesoderm is induced in the posterior region of the epiblast and undergoes an EMT to delaminate and migrate out of the streak.
Completion of EMT is dependent upon downregulation of E-cadherin. Once the mesoderm has exited the streak, it migrates anteriorly between the
epiblast and visceral endoderm layers. Primitive streak to the right in (E)–(I).This phenotype is strikingly similar to that of Fgfr1 and
Fgf8 mutant embryos (Deng et al., 1994; Sun et al., 1999;
Yamaguchi et al., 1994). Fgfr1 is required for the expres-
sion of a series of mesoderm-specific markers such as
Sprouty2, Tbx6, Brachyury, and Lim1; moreover, Fgfr1 is
required for the expression ofSnail, which mediates down-
regulation of the transcript for the E-cadherin cell adhesion
protein to promote EMT (Ciruna and Rossant, 2001). How-
ever, in contrast to Fgf mutants, Sprouty2, Tbx6, and962 Cell 125, 957–969, June 2, 2006 ª2006 Elsevier Inc.Brachyury are correctly expressed in p38IPRRK/RRK mutant
embryos (Figures 4A–4F). In wild-type embryos, Lim1 is
expressed at higher levels in cells as they migrate away
from the primitive streak (Barnes et al., 1994). In mutant
embryos, Lim1 is expressed, although in a more limited
range (Figures 4G and 4H), suggesting that cells are
turning on the mesenchymal developmental program but
nevertheless fail to properly migrate away from the
streak.
At E8.5, examination of molecular marker expression
reveals that mesoderm is properly specified although dis-
organized in mutant embryos (Figures 4I–4T). Presomitic
mesoderm is specified as evidenced by Fgf8 and Tbx6
expression (Figures 4I, 4J, 4M,and 4N). Mox1, a somite
marker, is expressed in mutant embryos, although not or-
ganized into somitomeres (Figures 4K and 4L). Less se-
verely affected mutant embryos do form some anterior so-
mites as evident by expression of Twist (Figures 4S and
4T). Often the paraxial mesoderm is not divided into dis-
crete left and right domains, likely due to defects in devel-
opment of the midline. Examination ofBrachyury, a midline
Figure 4. Mesoderm Is Properly Specified in p38IPRRK/RRK
Mutant Embryos But Disorganized
Expression of molecular markers of mesoderm at E7.5: Sprouty2 (A
and B), Brachyury (C and D), Tbx6 (E and F), and Lim1 (G and H) ex-
pression in p38IP+/+ (A, C, E, and G) and p38IPRRK/RRK mutant (B, D,
F, and H) embryos. Primitive streak to the right in (A)–(H). Expression
of molecular markers at E8.5: Fgf8 (I and J), Mox1 (K and L), Tbx6 (M
and N), Snail (O and P), Brachyury (Q and R), and Twist (S and T) in
p38IP+/+ (I, K, M, O, Q, and S) and p38IPRRK/RRK mutant (J, L, N, P,
R, and T) embryos.axial mesoderm marker, shows that the midline is present
in mutant embryos but is often severely disrupted and dis-
continuous (Figures 4Q and 4R). Less severely affected
embryos, however, show division of Snail and Twist ex-
pression into discrete left and right domains, indicating
a more normal midline (Figures 4O, 4P, 4S, and 4T). These
results indicate that both axial and nonaxial mesoderm
is specified in p38IPRRK/RRK mutant embryos but dis-
organized.
p38IP Is Required for Downregulation of E-Cadherin
To determine if these defects in mesoderm migration are
related to defects in p38 activation, p38 phosphorylation
was determined in the primitive streak of E7.5 wild-type
and mutant embryos. In wild-type embryos, phosphory-
lated p38 is detected ubiquitously in all germ layers (Fig-
ures 5A–5C). Despite the ubiquitous expression pattern
of p38IP, in mutant embryos, phosphorylated p38 is not
detected specifically in the primitive streak (between ar-
rows) and in the mesoderm that fails to migrate away
from the streak (arrowhead, Figures 5D–5F). Phosphory-
lated p38 is detected, however, in the rest of the embryo,
including the few mesoderm cells that are able to migrate
away from the primitive streak.
Fgfr1 regulates the expression ofSnail transcript and the
Snail protein represses E-cadherin transcription to pro-
mote EMT (Ciruna and Rossant, 2001). To determine if
this pathway is disrupted in p38IPRRK/RRKmutant embryos,
the expression of Snail and E-cadherinwas examined dur-
ing gastrulation. Snail is expressed at normal levels in the
primitive streak of mutant embryos, indicating that p38IP
is not required for regulation of Snail expression (Figures
5G and 5J). Consistent with the expression of Snail, which
acts as a transcriptional repressor at the E-cadherin pro-
moter, the E-cadherin transcript is downregulated in the
mesoderm of mutant embryos, although these cells fail
to migrate (Figures 5H and 5L).
The E-cadherin protein is localized to the adherence
junctions of cells in the epithelium, and the E-cadherin
transcript gets rapidly downregulated as cells exit the ep-
ithelial cell layer (Figure 5I). Yet, in the cells that have just
exited the epithelial layer and downregulated the E-cad-
herin transcript, E-cadherin protein is still present at the
junctions and gets downregulated as cells migrate away
from the streak (Figure 5M). This observation suggests
that E-cadherin protein expression is also regulated post-
transcriptionally. To determine if p38IP is required for
posttranscriptional regulation of E-cadherin, E-cadherin
protein expression was examined in mutant embryos
(Figures 5N and 5O). Strikingly, in mutant embryos, the
E-cadherin protein remains localized to the junction of
the cells that fail to migrate away from the primitive streak.
These results raise the intriguing possibility that two path-
ways act independently to regulate E-cadherin in the
primitive streak to allow mesoderm migration: Fgf/Snail
acts at the transcriptional level to downregulate the
E-cadherin transcript and p38IP acts to downregulate or
destabilize the E-cadherin protein.Cell 125, 957–969, June 2, 2006 ª2006 Elsevier Inc. 963
Figure 5. p38IP Is Required for Activation of p38 in the Primitive Streak and for Downregulation of E-Cadherin Protein Indepen-
dently of Snail
(A–F) In E7.5 p38IP+/+ embryos (A–C), p38 is activated throughout the embryo as revealed by immunofluorescence using anti-phospho-p38 antibody
(P-p38). In p38IPRRK/RRK mutant embryos (D–F), p38 is not phosphorylated specifically in the primitive streak (between arrows in F) and mesoderm
that fails to migrate away from the primitive streak (arrowhead in F). Open arrowhead indicates some of the few mesoderm cells that migrated away
from the primitive streak and activated p38. (C) and (F) show overlay of P-p38 localization (A and D) and nuclei (B and E). Regions where p38 is ac-
tivated are in pink while regions where p38 is not activated are blue.
Snail is expressed in the primitive streak of E7.5 p38IP+/+ (G) and p38IPRRK/RRK mutant (J) embryos. As mesoderm leaves the primitive streak, E-cad-
herin expression is downregulated in p38IP+/+ embryos at both the transcriptional (H and I) and protein (M and N) levels, whereas in p38IPRRK/RRK
mutants the E-cadherin transcript is downregulated (L) but not the protein (O) in cells that fail to migrate away from the streak (arrowhead). Markers
of EMT such as Integrin-a5 (P) and Fibronectin (R) are upregulated in mesoderm as it migrates away from the primitive streak of wild-type embryos.
Integrin-a5 (Q) and Fibronectin (S) are upregulated normally (arrowhead) in cells that fail to migrate from the p38IPRRK/RRK mutant streak. b-catenin
expression in wild-type (T) and p38IPRRK/RRK mutant (U) embryos highlights the epithelial and mesenchymal cell morphologies. E-cadherin-positive
cells that fail to migrate away from the streak exhibit a mesenchymal morphology (arrowhead). Primitive streak is to the right in (A)–(U).When cells undergo EMT, the expression levels of
a number of cell adhesion markers become either up- or
downregulated. To determine if p38IP is required for other
aspects of EMT, additional EMT markers were examined in
mutant embryos. Markers of mesoderm migration such as
Integrin-a5 and Fibronectin are efficiently upregulated in
mutant mesoderm that fails to migrate away from the prim-
itive streak (Figures 5P–5S). In addition, as cells delami-
nate from the primitive streak, they change morphology
as highlighted by staining with an anti-b-catenin antibody964 Cell 125, 957–969, June 2, 2006 ª2006 Elsevier Inc.(Figures 5T and 5U). Taken together, these results suggest
that while p38IPRRK/RRK mutant mesoderm undergoes
a partial EMT, it fails to complete EMT and downregulate
the E-cadherin protein.
To study further the requirement for p38IP in mesoderm
migration, mesoderm from the primitive streak of E7.5
wild-type embryos or the cells that fail to migrate away
from the primitive streak of mutant embryos were dis-
sected and cultured on fibronectin-coated plates. Wild-
type mesoderm migrates extensively away from the
Figure 6. p38IP and p38 Are Required for
Downregulation of E-Cadherin in a Fgf-
Independent Pathway
(A–L) Cultured primitive streak explants were
costained with anti-E-cadherin antibody (A, C,
E, G, I, and K) and the nuclear stain Hoechst
to visualize the cells that no longer express E-
cadherin (B, D, F, H, J, and L). Dotted red line
indicates border of E-cadherin expression
and dotted blue line indicates border of
Hoechst staining. Wild-type mesoderm cells
from primitive streak explants (A and B) down-
regulate E-cadherin expression and migrate
extensively away from the explant, while cells
from p38IPRRK/RRK mutant embryos (C and D)
fail to downregulate E-cadherin and do not mi-
grate away from the streak. Incubation of
p38IPRRK/RRK mutant primitive streak with the
anti-function E-cadherin antibody results in
downregulation of E-cadherin expression and
extensive migration of mesoderm away from
the streak (E and F). Cells from primitive streak
explants from E7.5 p38IP+/+ embryos incu-
bated with DMSO downregulate E-cadherin
and migrate away from the explant (G and H),
while cells from explants incubated with 20
mM p38 kinase inhibitor SB203580 do not
downregulate E-cadherin or migrate (I and J),
whereas coincubation with 20 mM SB203580
plus the anti-function E-cadherin antibody res-
cues EMT and mesoderm migration (K and L).
Activation of p38 is impaired in the primitive
streak of NIK but not Fgf8 mutant embryos.
Phospho-p38 expression in E7.5 wild-type
(M), Fgf8/ (N), and NIK/ (O) mutant em-
bryos. p38 is activated in cells that fail to migrate from the primitive streak in Fgf8/ mutant embryos (open arrow in N). In NIK/ mutant embryos
(O), p38 is not phosphorylated specifically in the primitive streak (between arrows) and mesoderm that fails to migrate away from the primitive streak
(arrowhead). White dotted line highlights epiblast. Primitive streak is to the right.explant coincident with the downregulation of E-cadherin
protein (Figures 6A and 6B and Burdsal et al., 1993). As
seen in vivo, cells from the mutant primitive streak that
failed to downregulate E-cadherin also failed to migrate
when explanted (Figures 6C and 6D). To determine
whether p38IPRRK/RRK mutant cells can migrate if E-cad-
herin function is blocked, explants were incubated with
a function-perturbing anti-E-cadherin antibody. This re-
sulted in both the downregulation of E-cadherin and exten-
sive migration of mutant cells away from the explant (Fig-
ures 6E and 6F). These results suggest that p38IPRRK/RRK
mutant cells likely remain in the primitive streak due to a
deficiency in the downregulation of E-cadherin protein, but
otherwise p38IP is not required for general cell migration.
p38 Activity Is Required for E-Cadherin
Downregulation
p38IPRRK/RRK mutant embryos fail to activate p38 specifi-
cally in the primitive streak and the mesoderm that
fails to downregulate E-cadherin (Figures 5F and 5O). To
determine if the failure to downregulate E-cadherin in
p38IPRRK/RRKmutant embryos is due to a failure to activate
p38 in the primitive streak, explants from wild-type em-
bryos were cultured in the presence of either a specificp38 kinase inhibitor or vehicle control (DMSO). The chemical
inhibitorSB203580 targets bothp38aandp38bbut notp38d
or p38g (Cuenda et al., 1995). In control explants incubated
with DMSO, cells are capable of downregulating E-cadherin
and migrating away from the explant (Figures 6G and 6H).
In contrast, explants treated with 20 mM SB203580 did not
downregulate E-cadherin and failed to migrate away from
the explant (Figures 6I and 6J). This result indicates that
p38 activity is required for downregulation of E-cadherin
and EMT. To confirm this and to test whether p38 is also re-
quired for mesoderm migration after EMT, explants were
incubated in 20 mM SB203580 and the function blocking
anti-E-cadherin antibody (Figures 6K and 6L). Similar to
p38IPRRK/RRKmutant explants, addition of anti- E-cadherin
antibody rescued EMT and cell migration. These results
indicate that both p38IP and p38 are required for downre-
gulation of E-cadherin but not for mesoderm migration.
p38 Acts Downstream of NIK in MesodermMigration
To determine if Fgf signaling is required for p38 activation
in the primitive streak, p38 phosphorylation was examined
in Fgf8 mutant embryos (Figures 6M and 6N). In contrast
to p38IPRRK/RRK mutants (Figures 5D–5F), Fgf8 mutant
embryos showed robust activation of p38 in the primitiveCell 125, 957–969, June 2, 2006 ª2006 Elsevier Inc. 965
streak and the cells that fail to migrate. The Drosophila ho-
molog of NIK/Map4k4, Misshapen (Msn), requires p38 ac-
tivity for some in vivo responses (Paricio et al., 1999), and
the phenotype of NIK/ embryos (Xue et al., 2001) is sim-
ilar to that of p38IPRRK/RRK, suggesting that they may act in
a similar pathway. Similar to p38IPmutant embryos, p38 is
not activated in the primitive streak (between arrows) or
the mesoderm that accumulates in the streak of NIK mu-
tant embryos (arrowhead, Figure 6O). These data indicate
that NIK may act upstream of p38 in a pathway to promote
EMT and that this pathway is independent of Fgf signaling.
This possibility is also supported by the similarities in ex-
pression of mesoderm markers in p38IPRRK/RRK and NIK
mutant embryos as compared to Fgf8 or Fgfr1mutant em-
bryos (Deng et al., 1994; Sun et al., 1999; Xue et al., 2001;
Yamaguchi et al., 1994).
DISCUSSION
Here we identify a p38-interacting protein (p38IP) that is
required to bind and activate p38 during mouse develop-
ment. Loss of p38IP function causes severe embryonic
defects. A splicing mutation in p38IP results in a variety
of incompletely penetrant phenotypes including neural
tube, eye, and gastrulation defects. A stronger p38IP allele
results in completely penetrant gastrulation defects in
which mesoderm migration away from the primitive streak
is impaired, although mesoderm induction, patterning,
and migratory behavior are not affected. These defects
arise due to disruption of p38 activation leading to a de-
creased ability of specified mesoderm cells to downregu-
late the E-cadherin protein and complete EMT.
Figure 7. Model for Pathways Resulting in E-Cadherin Down-
regulation
Fgf signaling through Fgfr1 results in activation of two pathways regu-
lating mesoderm cell fate (expression of Tbx6 and Brachyury) or meso-
derm migration. To regulate mesoderm migration, Fgf signaling is re-
quired for expression of Snail, which downregulates expression of
the E-cadherin transcript. In an independent pathway, NIK/Map4k4
is needed for activation of p38, and p38IP is also required for activation
of p38 in vivo. p38 and p38IP activity are required for downregulation of
the E-cadherin protein. Both the Fgf/Snail and NIK/p38/p38IP path-
ways are required to ensure a robust EMT and to allow mesoderm to
migrate from the primitive streak.966 Cell 125, 957–969, June 2, 2006 ª2006 Elsevier Inc.Outlined in our model (Figure 7), our data reveal an ad-
ditional mechanism of E-cadherin regulation in the gastru-
lating mouse embryo that is independent of the Fgf8/Snail
pathway. We show that NIK/p38/p38IP do not affect Snail
expression or the normal repression of E-cadherin tran-
scription. Instead, the NIK/p38/p38IP pathway is required
to properly downregulate E-cadherin protein expression.
Our results suggest that two pathways—Fgf/Snail and
NIK/p38/p38IP—act independently and converge on
E-cadherin expression: one at the transcriptional level and
one at the protein level to insure the rapid downregulation
of E-cadherin and a robust EMT; and disruption of either
pathway leads to defective gastrulation.
p38IP Regulates p38 Activity In Vivo
We demonstrate that p38IP specifically binds p38 in both
yeast two-hybrid and coimmunoprecipitation assays. We
mapped the binding domain to the C-terminal region of
p38IP. Significantly, the mutations in both the p38IPRRK
and p38IPdrey alleles result in deletion of the C-terminal
domain of p38IP, and these mutant proteins cannot bind
to p38. Furthermore, we demonstrate that p38 activation
in vivo is compromised in both p38IPRRK and p38IPdrey
mutants. Future experiments are required to elucidate
the biochemical mechanism(s) by which p38IP functions
to regulate p38.
We found that p38IP binds to only p38a in a yeast two-
hybrid assay, yet previous studies of p38a mutant em-
bryos demonstrated that p38a is essential for develop-
ment of the placenta but not for gastrulation (Adams
et al., 2000; Mudgett et al., 2000). This raises the possibility
that p38IP may be required for activation of other p38 iso-
forms in vivo. To begin to investigate this possibility, we de-
termined the expression pattern of p38b, p38g, and p38d
to determine if the other p38 isoforms are expressed in
the primitive streak. p38g and p38d are expressed in the
extraembryonic regions of the gastrula while p38b is ex-
pressed in the epiblast (Figure S1). This data combined
with studies in explanted mesoderm in which an inhibitor
of p38a and p38b prevents EMT (Figure 6) suggest that
p38IP may be required for activation of both p38a and
p38b in vivo. An alternate explanation is that p38amay nor-
mally mediate EMT in the primitive streak but in the ab-
sence of p38a, p38b may be able to compensate either
by altering its normal expression pattern or activity. In sup-
port of these ideas, we examined activation of p38 in p38a
mutant gastrula stage embryos and found that p38 is phos-
phorylated normally throughout the epiblast and streak
(I.E.Z. and L.N., unpublished data). In addition, we cannot
exclude the possibility that p38IP is also required for the
function of other, yet to be discovered, factors.
p38 Is Downstream of NIK
Our data provide an intriguing link between p38 activation
and the NIK pathway. This relationship to NIK is surprising
as NIK activates JNK but not p38 in cultured cells (Su et al.,
1997). Similarly, Misshapen (Msn), the Drosophila NIK ho-
molog, activates JNK to regulate dorsal closure (Su et al.,
1998), and Msn couples Frizzled and Disheveled to JNK
activation to regulate planar cell polarity in the Drosophila
wing and eye (Paricio et al., 1999). Interestingly in this con-
text, JNK acts redundantly with Dp38a and Dp38b, sug-
gesting that Msn is capable of regulating p38 activity in
vivo. During mouse embryogenesis, a role for NIK in eye
and neural tube morphogenesis has not been determined
as NIK mutant embryos die around E9.5 (Xue et al., 2001).
However, JNK mutant embryos (either single or double
mutants) do not exhibit the severe gastrulation defects ob-
served in NIK mutant embryos (Kuan et al., 1999; Sabapa-
thy et al., 1999), suggesting that NIK may activate JNK-in-
dependent pathways in vivo. Indeed, our studies indicate
that p38 activity is specifically disrupted inNIKmutant em-
bryos, and mutations in eitherNIK or p38IP result in similar
gastrulation defects, providing additional in vivo support
for a link between NIK and p38 activation.
p38IP and Neural Tube Defects
Neural tube defects (NTDs) occur when the neural tube
fails to close completely during embryogenesis leading
to exencephaly/anencephaly and spina bifida. NTDs are
one of the most common birth defects observed in humans
and represent a complex genetic disease (reviewed in
Copp et al., 2003). The mouse has provided over 100 po-
tential candidate genes for NTDs, and in some instances
mutations in these genes have been identified in human
patients (reviewed in Copp et al., 2003; Zohn et al.,
2005). Furthermore, identification of hypomorphic muta-
tions associated with NTDs indicates that these types of
mutations will reveal many more potential candidate
genes. We show that a severe allele ofp38IP results in gas-
trulation defects whereas the milder drey allele results in
exencephaly and spina bifida. Future experiments will de-
termine if the morphogenic defects in drey mutant mice
such as the failure to close the neural tube and eye defects
are due to specific defects in p38 activation.
EMT and Metastasis during Cancer
The EMT that occurs in the primitive streak of the gastru-
lating mouse embryo and during invasion and metastasis
of tumor cells involve regulation of E-cadherin expression
by Snail (reviewed in Barrallo-Gimeno and Nieto, 2005).
Furthermore, the loss of E-cadherin expression is a central
event in the transition of tumors from noninvasive to inva-
sive carcinomas (Batlle et al., 2000; Cano et al., 2000).
Here we present evidence of a Snail-independent path-
way in which p38 is required in the primitive streak to
downregulate E-cadherin expression at the posttranscrip-
tional level. Whether this Snail-independent, p38-depen-
dent pathway also functions in EMT during tumor invasion
remains to be determined.
EXPERIMENTAL PROCEDURES
Mouse Strains and Genotyping
drey was identified in a screen for recessive ENU-induced mutations
that cause morphological abnormalities at E12.5 (Garcia-Garciaet al., 2005; Kasarskis et al., 1998; Zohn et al., 2005). The dreymutation
was generated on a C57BL/6J genetic background and backcrossed
to C3H. In a mapping cross of 480 opportunities for recombination,
drey was mapped between Massachusetts Institute of Technology
(MIT) simple sequence length polymorphism (SSLP) markers D3mit6
and D3mit137. For high-resolution mapping, additional polymorphic
DNA markers were generated based on nucleotide repeat sequences
(see http://mouse.ski.mskcc.org/ for primer sequences). A mouse em-
bryonic stem (ES) cell line carrying an insertion in the p38IP gene
(RRK304) was obtained from BayGenomics http://baygenomics.ucsf.
edu/ database. Other mutant mouse lines used were Fgf8 and NIK
(Meyers et al., 1998; Xue et al., 2001).
Molecular Identification of drey Mutation
cDNAs of the p38IP gene were amplified by RT-PCR (Superscript One-
Step RT-PCR, Invitrogen) using RNA from E10.5 drey/drey and C57BL/
6 control embryos. The splice site junctions around exon 14 were se-
quenced and a T to C transition discovered in the splice donor consen-
sus sequence. Sequencing was confirmed using ten additional drey/
drey mutant embryos.
Analysis of Mutant Phenotype
Whole-mount and section RNA in situs were performed as described
(Holmes and Niswander, 2001; Liu et al., 1998). p38IP expression pat-
tern was determined using an antisense RNA probe synthesized from
IMAGE clone: 2598858 or by expression of the lacZ transcript in
p38IPRRK/+ embryos. Immunofluorescence experiments were per-
formed as described (Timmer et al., 2002) using anti-E-cadherin anti-
body (1:100 dilution of anti-uvomorulin antibody; Sigma F3648),
Hoechst (10 mg/ml; clone DECMA-1, Sigma), anti-Phospho-p38 MAP
Kinase (Thr180/Tyr182) antibody (1:100 dilution; Cell Signaling #9211),
anti-Phospho-ATF2 antibody (1:100 dilution; Cell Signaling #9221),
anti-Phospho-CREB antibody (1:100 dilution; Cell Signaling #9191),
anti-Integrin-a5 (1:100; BD-Pharmingen #553319), anti-fibronectin
(1:100; Sigma F3648), anti-b-catenin (1:1000; Sigma C7082).
Culture of Primitive Streak Explants
Primitive streak explants were dissected from E7.5 wild-type and mu-
tant embryos and grown on fibronectin-coated plates for 3 days as de-
scribed (Ciruna and Rossant, 2001). Media was supplemented with 20
mM SB203580 (Calbiochem) in DMSO and/or anti-E-cadherin (1:100
dilution of anti-uvomorulin antibody; Sigma).
Interaction of p38a with p38IP
To identify p38-interacting proteins, we used a kinase-inactive mutant
of p38a fused with the GAL4 DNA binding domain (pGBT9-p38(AF)) as
bait and performed a yeast two-hybrid screen of a Hela cell cDNA li-
brary constructed in the activation domain plasmid pACT as described
by the manufacturer (BD Clontech). Sequencing showed that the clone
encodes amino acids 381–733 of p38IP (1–733). PCR and Southern
blots were used to clone full-length human p38IP from a phage library.
The specificity of the interaction was tested by immunoprecipitation as
described (Ge et al., 2002).
Supplemental Data
Supplemental Data include one figure and can be found with this arti-
cle online at http://www.cell.com/cgi/content/full/125/5/957/DC1/.
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